Treatment of gastrointestinal tumors with MAb17-1A.
Frödin
J E
JE
Department of Oncology (Radiumhemmet), Karolinska Hospital, National Bacteriological Laboratory 6, Stockholm, Sweden.
Biberfeld
P
P
Christensson
B
B
Pihlstedt
P
P
Shetye
J
J
Makower
J
J
Wahren
B
B
Mellstedt
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006207:Half-Life; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D051379:Mice; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; C400149:Edrecolomab